Exagen (XGN) Total Non-Current Liabilities (2018 - 2026)

Exagen has reported Total Non-Current Liabilities for 9 years, with the latest figure at $36.8 million in Q1 2026.

• For the quarter ending Q1 2026, Total Non-Current Liabilities rose 8.85% year-over-year to $36.8 million; the trailing twelve-month figure through Mar 2026 stood at $36.8 million (up 8.85% YoY), and the FY2025 full-year result was $38.8 million, up 10.45% from the prior year.
• Total Non-Current Liabilities for Q1 2026 stood at $36.8 million, down from $38.8 million in the prior quarter.
• The five-year high for Total Non-Current Liabilities was $45.1 million in Q1 2022, with the low at $30.5 million in Q1 2024.
• Historically, Total Non-Current Liabilities has averaged $36.8 million across 5 years, with a median of $35.1 million in 2024.
• Annual changes were most pronounced in 2022 — Total Non-Current Liabilities climbed 29.28% — and 2024, when it retreated 28.24%.
• Exagen's Total Non-Current Liabilities stood at $42.9 million in 2022, then slipped by 20.98% to $33.9 million in 2023, then gained by 3.71% to $35.1 million in 2024, then climbed by 10.45% to $38.8 million in 2025, then slipped by 5.31% to $36.8 million in 2026.
• The last three Total Non-Current Liabilities figures came in at $36.8 million (Q1 2026), $38.8 million (Q4 2025), and $38.1 million (Q3 2025), per Business Quant data.